Data from: Microvesicle release drive cycles of mitophagy flux disruption and inflammatory amplification in sepsis-induced myocardial dysfunction
Data files
Mar 06, 2026 version files 411.66 MB
-
PNAS_Data_Bankup.zip
411.64 MB
-
README.md
13.29 KB
Abstract
Sepsis-induced myocardial dysfunction strongly contributes to high mortality in patients with sepsis by exacerbating systemic organ failure; however, the onset and molecular mechanisms driving this vicious cycle remain unclear. Here, we revealed that DRP1-mediated mitochondrial fission and excessive reactive oxygen species accumulation are central to disrupting mitophagy flux and triggering inflammatory cascades. Using cecal ligation and puncture mice and lipopolysaccharide-treated HL-1 cell models, combined with advanced imaging and molecular analyses, we demonstrated that elevated reactive oxygen species activates the RIP1/RIP3 pathway, impairing mitophagy flux and promoting the release of microvesicles containing mitochondrial inner membrane components and mitochondrial DNA. These microvesicles amplify inflammatory responses through the cGAS-STING and RIP1/RIP3 pathways, driving the production of damage- and pathogen-associated molecular patterns. This study highlights two interlinked vicious cycles, mitophagy flux disruption and damage- and pathogen-associated molecular pattern amplification, as critical drivers of sepsis-induced myocardial injury, providing novel therapeutic targets for mitigating inflammatory damage and improving clinical outcomes in patients with sepsis.
Dataset DOI: 10.5061/dryad.z34tmpgth
Description of the data and file structure
File: PNAS_Data_Bankup.zip
Description: This folder contains all the data used for the figures in my submitted manuscript. The file names are organized according to the figure order, and within each file, subfolders are named according to the order of the panels, with the corresponding data provided.
Figure 1
A. The raw data of western blot.
B. IF images showing co‐location of DRP1 and mitochondria (COX IV) in the myocardial tissue after CLP, n = 8 per group, scale bar = 25μm.
C. Activation level and quantification of DRP1 protein of myocardial tissue after CLP, n = 8 per group.
D. EM images showing mitochondria in the myocardial tissue of Sham, CLP, and CLP+Mdivi-1 (25mg/kg) group, n = 8 per group, scale bar = 2μm.
E F. Quantification of DHE and DCFH-DA level of myocardial tissue of Sham, CLP, and CLP+Mdivi-1 (25mg/kg) group, n = 8 per group.
G. Fluorescence intensity and quantification of ROS/DCFH-DA and Mito-ROS/MitoSOX in HL-1 cells treated with LPS (10μg/mL),LPS+Mdivi-1 (50μM) or LPS+Mdivi-1 (100μM), n = 3 per group, scale bar = 50μm.
H I. Ultrasound images of systolic and diastolic function as well as cardiac strain in Sham, CLP or CLP+Mdivi-1 (25mg/kg) group, n = 5 per group.
Figure 2
A B. F images showing co‐location of p62 and mitochondria (COX IV) of the myocardial tissue after CLP or treated with Mdivi-1 (25mg/kg), n = 8 per group, scale bar = 25μm.
C D E. LC3 expression level of myocardial tissue after CLP or treated with Mdivi-1 or NAC (100mg/kg), n = 8 per group; p62 expression level and quantification in total, cytoplasmic and mitochondrial of myocardial tissue after CLP or treated with Mdivi-1 or NAC, n = 8 per group.
F G H I. WB analysis and CO‐IP assay showing RIP3 phosphorylation and RIP1‐RIP3 binding ability of the myocardial tissue after CLP or treated with Mdivi-1or NAC, n = 8 per group; WB analysis and CO‐IP assay showing RIP3 phosphorylation and RIP1‐RIP3 binding ability of the HL-1 cells treated with LPS, LPS+Mdivi-1 or LPS+NAC, n = 3 per group.
Figure 3
A. HIS-SIM images of HL-1 cells treated by LPS (10μg/mL), LPS+Mdivi-1 (50μM), LPS+NAC (1mM), LPS+Nec-1 (10μM) and LPS+Nec-1 (50μM). Cells were labeled by PK Mito (magenta), LC3B-mCherry-GFP (LC3B marker, red and green), n = 3 per group, scale bar = 10μm.
B. HIS-SIM images showing co-location of lysosome and mitophagosome in HL-1 cells treated by LPS, LPS+Mdivi-1 (50μM), LPS+NAC (1mM), LPS+Nec-1 (10μM) and LPS+Nec-1 (50μM). Cells were labeled by Lamp1 (magenta), LC3B-mCherry-GFP (LC3B marker, red and green), n = 3 per group, scale bar = 10μm.
C. Confocal fluorescence images of HL-1 cells stained with JC-1 to assess MMP (mitochondrial membrane potential) under Normal, LPS, and LPS+Nec-1 (50μM) conditions. Mitochondria with high membrane potential exhibit red fluorescence, whereas depolarized mitochondria show green fluorescence, n = 3 per group, scale bar = 25μm.
D. Seahorse XF analysis of mitochondrial respiration in HL-1 cells under Normal, LPS (10μg/mL), and LPS+Nec-1 (50μM) conditions. Basal respiration and maximal respiration were quantified using Seahorse Wave software. n = 3 per group.
E. High-resolution respirometry (Oroboros O2k) analysis of cardiac mitochondria isolated from Normal, CLP, and CLP+Nec-1 (5mg/kg) mice. Oxygen consumption was recorded under LEAK, OXPHOS, and ETS states.
Figure 4
A. Confocal images and quantification analysis showing co‐location of p62 and aggresomes in HL-1 cells treated with LPS (10μg/mL), n = 3 per group, scale bar = 25μm.
B. TEM images showing monolayer structures of extracellular vesicles after CLP, n = 6 per group, scale bar = 500nm.
C. Expression level of CD9, CD63 and CD81 in extracellular vesicles of myocardial tissue after CLP, n = 6 per group.
D. NTA particle analysis of extracellular vesicles from myocardial tissue after CLP. NTA ordinate refers to the number of extracellular vesicles, and NTA abscissa refers to the diameters of the extracellular vesicles, n = 6 per group.
E. onfocal images and quantification analysis showing co‐location of p62 and CD63 of extracellular vesicles from myocardial tissue after CLP, n = 6 per group, scale bar = 25μm.
F. xpression level of p62 and CD63 in HL-1 cells after treated with LPS, LPS+Mdivi-1 (50μM) or LPS+NAC (1mM), n = 3 per group.
G. Expression level of p62 and CD63 in HL-1 cells after treated with LPS, LPS+Nec-1(10μM) and LPS+Nec1(50μM), n = 3 per group.
H. TEM images showing monolayer structures of extracellular vesicles of Sham, CLP, and CLP+Nec-1 (5mg/kg), n = 6 per group, scale bar = 500nm.
I. NTA particle analysis of extracellular vesicles from myocardial tissue of Sham, CLP, and CLP+Nec-1 (5mg/kg). NTA ordinate refers to the number of extracellular vesicles, and NTA abscissa refers to the diameters of the extracellular vesicles, n = 6 per group.
J. ONI images showing the expression and spatial distribution of p62 within extracellular vesicles derived from Sham, CLP, and CLP+Nec-1 (5mg/kg) groups, n = 6 per group, scale bar = 300 nm.
Figure 5
(A) The content of TNF-α, IL-1β and IL-6 in the supernatant of HL-1 cells treated with LPS or microvesicles derived from Sham mice or CLP mice, n = 3 per group.
(B) Expression level of RIP3 and p-RIP3 in HL-1 cells after treated with LPS or microvesicles derived from CLP mice, n = 3 per group.
(C) CO‐IP assay showing RIP1‐RIP3 binding ability of the HL-1 cells treated with LPS or microvesicles derived from CLP mice, n = 3 per group.
(D) HIS-SIM images of HL-1 cells treated with LPS or microvesicles derived from CLP mice.Cells were labeled by PK Mito (magenta), LC3B-mCherry-GFP (LC3B marker, red and green), n = 3 per group, scale bar = 10μm. Numbers of mitophagosomes and mitolysosomes were quantified using ImageJ.
(E) HIS-SIM images showing co-location of lysosome and mitophagosome of HL-1 cells treated with LPS or microvesicles derived from CLP mice. Cells were labeled by Lamp1 (magenta), LC3B-mCherry-GFP (LC3B marker, red and green), n = 3 per group, scale bar = 10μm.
(F) Quantification analysis of the content of TNF-α, IL-1β and IL-6 in the supernatant of HL-1 cells treated with microvesicles derived from CLP mice or treated with Nec-1 (50μM), n = 3 per group.
(G-H) IHC images and quantification analysis showing the content of TNF-α, IL-1β and IL-6 in the myocardial tissue after CLP or treated with Nec-1 (5mg/kg), scale bar = 100μm, n = 6 per group.
(I) Ultrasound detection for mice systolic and diastolic function after CLP or treated with Nec-1, n = 6 per group.
Figure 6
(A) Quantification analysis of cytometry detection of cardiolipin (%) in microvesicles from HL-1 cells treated with LPS or Nec-1 (50μM), n = 3 per group.
(B) Quantification analysis of mtDNA copy number in microvesicles from HL-1 cells treated with LPS or Nec-1 (50μM), n = 3 per group.
(C) WB analysis of matrix Aco2 and IMM COX IV of microvesicles from HL-1 cells treated with LPS or Nec-1 (50μM), n = 3 per group.
(D) Quantification analysis of cytometry detection of cardiolipin (%) in microvesicles from myocardial tissue after CLP or treated with Nec-1 (5mg/kg), n = 8 per group.
(E) Quantification analysis of mtDNA copy number in microvesicles from myocardial tissue after CLP or treated with Nec-1 (5mg/kg), n = 8 per group.
(F) WB analysis of matrix Aco2 and IMM COX IV of microvesicles from myocardial tissue after CLP or treated with Nec-1 (5mg/kg), n = 8 per group.
(G) ONI images showing the expression and spatial distribution of TFAM within extracellular vesicles derived from Sham, CLP, and CLP+Nec-1 (5mg/kg) groups, n = 6 per group, scale bar = 300 nm.
(H) ONI images showing the expression and spatial distribution of COX IV within extracellular vesicles derived from Sham, CLP, and CLP+Nec-1 (5mg/kg) groups, n = 6 per group, scale bar = 300 nm.
(I) HIS-SIM images of HL-1 cells treated by LPS or LPS+Nec-1 (50μM). Cells were labeled by Tom20 (green), PK Mito (magenta), mtDNA (yellow), n = 3 per group, scale bar = 10 μm. The white box indicated the sites of outer mitochondrial membrane disruption.
(J) 3D reconstruction of the outer mitochondria membrane (blue), inner mitochondria membrane (red) and mtDNA (yellow) of HL-1 cells treated by LPS or LPS+Nec-1 (50μM), n = 3 per group, scale bar = 1 μm. The white box indicated the sites of outer mitochondrial membrane disruption.
(K) Time-lapse recording of the mitochondria outer membrane rupture in HL-1 cells after treated with LPS or LPS+Nec-1 (50μM) by HIS-SIM, n = 3 per group, scale bar = 10 μm.
Figure 7
(B) Fluorescence intensity of mCherry-labeled Staphylococcus Aureus or GFP-labeled Escherichia Coli in HL-1cells treated withmicrovesicles from cell supernatant treated with LPS or LPS+Nec-1(50μM), or from myocardial tissue after CLP or CLP treated with Nec-1 (5mg/kg), n = 3 per group, scale bar = 200μm.
(C) WB analysis of cGAS-STING pathway in HL-1 cells treated with microvesicles from cell supernatant treated with LPS or LPS+Nec-1(50μM), or from myocardial tissue after CLP or CLP treated with Nec-1 (5mg/kg), n = 6 per group.
(D) Elisa analysis of IFN-α and IFN-β in HL-1 cells treated with microvesicles from cell supernatant treated with LPS or LPS+Nec-1(50μM), or from myocardial tissue after CLP or CLP treated with Nec-1 (5mg/kg), n = 6 per group.
(F) HE staining images showing liver, kidney, heart and lung from C57 treated with microvesicles from myocardial tissue of Sham, CLP or CLP treated with Nec-1 (5mg/kg), n = 8 per group, scale bar = 100μm. The regions marked by white boxes indicated areas with pronounced pathological changes.
(G) Analysis of CFU from C57 mice treated with microvesicles from myocardial tissue of Sham, CLP or CLP treated with Nec-1 (5mg/kg), n = 8 per group.
Result_LPS_vs_CON_annotation_all
This table presents proteomic data of vesicles derived from HL-1 cells under control conditions and after LPS treatment.
S Figure 1
WB and Co-IP analysis showing enhanced DRP1 SUMOylation in myocardial tissue after CLP, n = 8 per group.
S Figure 2
(A) WB analysis showing DRP1 subcellular distribution in HL-1 cells, n = 3 per group.
(B) Immunofluorescence imaging confirming DRP1 translocation from the cytosol to mitochondria after LPS stimulation, which was reversed by Mdivi-1 treatment. Cells were stained for DRP1 (green), mitochondria (red), and nuclei (blue), n = 3 per group, Scale bar = 25 μm.
S Figure 3
Single-channel images of Figure 3B. HIS-SIM images of HL-1 cells treated by LPS, LPS+Mdivi-1 (50μM), LPS+NAC (1mM), LPS+Nec-1 (10μM) or LPS+Nec-1 (50μM). Cells were labeled by Lamp1 (magenta), LC3B-mCherry-GFP (LC3B marker, red and green), n = 3 per group, scale bar = 10μm.
S Figure 4
Flow cytometric analysis of fluorescent signals in peripheral blood vesicles.
S Figure 5
Single-channel images of Figure 5E. HIS-SIM images of HL-1 cells treated with microvesicles from myocardial tissue after CLP or treated with Nec-1(50μM). Cells were labeled by Lamp1 (magenta), LC3B-mCherry-GFP (LC3B marker, red and green), n = 3 per group, scale bar = 10μm.
S Figure 6
(A) Flow cytometry gating strategy for analyzing the cardiolipin content within the core of extracellular microvesicles.
(B) Quantitative results showing the relative expression of mitochondrial matrix protein Aco2 and inner membrane protein COX IV, n = 3 per group.
(C)Quantitative results showing the relative expression of mitochondrial matrix protein Aco2 and inner membrane protein COX IV, n = 6 per group.
S Figure 7
Single-channel images of Figure 6I. HIS-SIM images of HL-1 cells treated by LPS or LPS+Nec-1. Cells were labeled by Tom20 (green), PK Mito (magenta), mtDNA (yellow), n = 3 per group, scale bar = 10μm.
S Figure 8
Western blot analysis and quantitative results showing the phosphorylation levels of TBK1 and IRF3 in HL-1 cells, n = 3 per group.
Supplementary Video 1. HIS-SIM video of HL-1 cells. Cells were labeled by Tom20 (green), PK Mito (magenta), mtDNA (yellow), scale bar = 10μm. The interval between each frame was 2 seconds.
Supplementary Video 2. HIS-SIM video of HL-1 cells treated with LPS. Cells were labeled by Tom20 (green), PK Mito (magenta), mtDNA (yellow), scale bar = 10μm. The interval between each frame was 2 seconds.
Supplementary Video 3.HIS-SIM video of HL-1 cells treated with LPS+Nec-1. Cells were labeled by Tom20 (green), PK Mito (magenta), mtDNA (yellow), scale bar = 10μm. The interval between each frame was 2 seconds.
Code/software
- Microsoft Office 2021 – for opening and editing Excel spreadsheets (.xlsx) containing raw and processed data.
- Fiji (ImageJ 2.9.0/2023-06-21) – for image analysis and quantification of microscopy data.
Access information
Other publicly accessible locations of the data:
- none
Data was derived from the following sources:
- none
